Open AccessA Randomized Trial in a Rare Cancer: Targeting CD30 in Cutaneous T Cell Lymphoma Yields Therapeutic Dividends
Author(s) -
Andrew W. Roberts
Publication year - 2017
Publication title -
the hematologist
Language(s) - English
Resource type - Journals
ISSN - 1551-8779
DOI - 10.1182/hem.v14.6.7793
Subject(s) - medicine , cd30 , lymphoma , randomized controlled trial , oncology , cancer , dermatology , cancer research